[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100588757":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":10,"enrollmentInfo":57,"targetDuration":10,"studyType":60,"phases":10,"briefSummary":61,"conditions":62,"keywords":66,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"IBD patient group",null,"Patients diagnosed with IBD according to clinical, imaging, endoscopic, and histopathological criteria.",[13],"Diagnostic Test: 18F-FAPI PET Imaging",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","18F-FAPI PET Imaging","The ROI of the target lesions was delineated based on 18F-FAPI PET Imaging, and the lesions were divided on the cross section to obtain the lesions SUVmax, SUVmean, SUVpeak, FAPI metabolic volume (FAV), MTV, TBR, and TLG.",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Wenbo Li, postgraduate","CONTACT","+8615292886778","lwb@tmmu.edu.cn",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"Army Medical Center of PLA, Daping Hospital, Army Medical University","RECRUITING","Chongqing","Chongqing Municipality","400042","China","CN",{"type":36,"coordinates":37},"Point",[38,39],106.55771,29.56026,{"lat":39,"lon":38},[42,44],{"name":43,"role":23,"phone":24,"phoneExt":10,"email":25},"Wenbo Li",{"name":45,"role":23,"phone":10,"phoneExt":10,"email":10},"Li",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100588757","evaluation-of-intestinal-lesions-and-disease-activity-in-inflammatory-bowel-disease-based-on-18f-fapi-pet-imaging-100588757",false,"NCT06945549","Evaluation of Intestinal Lesions and Disease Activity in Inflammatory Bowel Disease Based on 18F-FAPI PET Imaging","IBD，18F-FAPI","Inclusion Criteria:\n\n* Patients diagnosed with IBD according to clinical, imaging, endoscopic, and histopathological criteria;\n* Patients ≥18 years old;\n* 18F-FAPI PET\u002FCT intestinal imaging, conventional endoscopic and enhanced CT were performed within 1 week;\n* Intestinal segment matching was evaluated by endoscopy and imaging;\n* Patients voluntarily participate and sign informed consent.\n\nExclusion Criteria:\n\n* Pregnant or lactating patients;\n* Imaging images are of poor quality and cannot be used for diagnosis and evaluation;\n* Patients with contraindications for endoscopic or CT examination.","ALL","18 Years",{"count":58,"type":59},30,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to evaluate the role and effect of 18F-FAPI PET imaging in the identification of intestinal lesions and the assessment of disease activity in inflammatory bowel disease. The main question it aims to answer is:\n\nCan 18F-FAPI PET imaging effectively identify intestinal lesions in inflammatory bowel disease and accurately assess disease activity? Colonoscopy, enhanced abdominal CT, and 18F-FAPI intestinal imaging were completed within 1 week, and major adverse outcomes (MAO) were followed up 12 months after enrollment.\n\nLast updated on March 25, 2025",[63,64,65],"Inflammatory Bowel Disease (IBD)","Disease Activity","FAPI",[67,68,69],"Inflammatory bowel disease","18F-FAPI PET","disease activity","2025-06-25",{"date":72,"type":73},"2025-06-29","ACTUAL",{"date":75,"type":73},"2025-04-25",{"date":77,"type":59},"2027-12-31",{"name":5,"class":6},1]